Virion Therapeutics Provides Update on its VRON-0200 Clinical Development Program for HBV Functional Cure on World Hepatitis Day ...
PHILADELPHIA, PA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- Virion Therapeutics, LLC, a clinical-stage biotechnology company, developing novel T cell-based immunotherapies that utilize first-in-class checkpoint modifiers, today, on World …